169 related articles for article (PubMed ID: 33673169)
1. The
Nowak H; Vornweg S; Rump K; Rahmel T; Unterberg M; Koos B; Schenker P; Viebahn R; Adamzik M; Bergmann L
Cells; 2021 Feb; 10(2):. PubMed ID: 33673169
[TBL] [Abstract][Full Text] [Related]
2. NFKB1 promoter polymorphism: A new predictive marker of cytomegalovirus infection after kidney transplantation.
Leone F; Gigliotti P; La Russa A; Lofaro D; Perri A; Vizza D; Lupinacci S; Toteda G; Bonofiglio M; Presta P; Talarico R; Aquino B; Bonofiglio R
Transpl Infect Dis; 2019 Feb; 21(1):e13027. PubMed ID: 30431214
[TBL] [Abstract][Full Text] [Related]
3. NFKB1 promoter -94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients.
Elkhawaga SY; Gomaa MH; Elsayed MM; Ebeed AA
Clin Rheumatol; 2021 Jul; 40(7):2927-2937. PubMed ID: 33459954
[TBL] [Abstract][Full Text] [Related]
4. Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.
Zou YF; Wang F; Feng XL; Tao JH; Zhu JM; Pan FM; Su H
Tissue Antigens; 2011 Jan; 77(1):9-17. PubMed ID: 21155719
[TBL] [Abstract][Full Text] [Related]
5. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
[TBL] [Abstract][Full Text] [Related]
6. Interaction between obesity and the NFKB1 - 94ins/delATTG promoter polymorphism in relation to incident acute coronary syndrome: a follow up study in three independent cohorts.
Stegger JG; Schmidt EB; Berentzen TL; Tjønneland A; Vogel U; Rimm E; Sørensen TI; Overvad K; Jensen MK
PLoS One; 2013; 8(5):e63004. PubMed ID: 23671649
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphism of the NFKB1 gene promoter is not relevant in predisposition to celiac disease.
Rueda B; Núñez C; López-Nevot MA; Paz Ruiz M; Urcelay E; De la Concha EG; Martín J
Scand J Gastroenterol; 2006 Apr; 41(4):420-3. PubMed ID: 16635909
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
[TBL] [Abstract][Full Text] [Related]
9. Variations in Toll-like receptor and nuclear factor-kappa B genes and the risk of glioma.
Kına I; Sultuybek GK; Soydas T; Yenmis G; Biceroglu H; Dirican A; Uzan M; Ulutin T
Br J Neurosurg; 2019 Apr; 33(2):165-170. PubMed ID: 30450997
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers.
Lin SC; Liu CJ; Yeh WI; Lui MT; Chang KW; Chang CS
Cancer Lett; 2006 Nov; 243(1):47-54. PubMed ID: 16387424
[TBL] [Abstract][Full Text] [Related]
11. Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis.
Zou YF; Yuan FL; Feng XL; Tao JH; Ding N; Pan FM; Wang F
Cancer Invest; 2011 Jan; 29(1):78-85. PubMed ID: 21166501
[TBL] [Abstract][Full Text] [Related]
12. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
[TBL] [Abstract][Full Text] [Related]
13. The Aquaporin3 Promoter Polymorphism -1431 A/G is Associated with Acute Graft Rejection and Cytomegalovirus Infection in Kidney Recipients Due to Altered Immune Cell Migration.
Rump K; Rahmel T; Rustige AM; Unterberg M; Nowak H; Koos B; Schenker P; Viebahn R; Adamzik M; Bergmann L
Cells; 2020 Jun; 9(6):. PubMed ID: 32521638
[TBL] [Abstract][Full Text] [Related]
14. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.
Li P; Gu J; Yang X; Cai H; Tao J; Yang X; Lu Q; Wang Z; Yin C; Gu M
PLoS One; 2013; 8(8):e71604. PubMed ID: 23977085
[TBL] [Abstract][Full Text] [Related]
15. A multifactorial analysis of the pregnancy outcomes in cytomegalovirus-infected women.
Ding ZY; Xu F; Chen DZ; Meng XN; Xu TS; Lu MD; Zhuge HX
Gynecol Obstet Invest; 2015; 80(2):106-12. PubMed ID: 25792174
[TBL] [Abstract][Full Text] [Related]
16. Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients.
Lo SS; Chen JH; Wu CW; Lui WY
Surgery; 2009 Mar; 145(3):280-5. PubMed ID: 19231580
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
[TBL] [Abstract][Full Text] [Related]
18. A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.
Vangsted AJ; Klausen TW; Gimsing P; Andersen NF; Abildgaard N; Gregersen H; Vogel U
Haematologica; 2009 Sep; 94(9):1274-81. PubMed ID: 19734419
[TBL] [Abstract][Full Text] [Related]
19. NF-κB1 promoter-94ins/delATTG polymorphisms correlate with the acute exacerbation of chronic obstructive pulmonary disease.
Meng X; Zheng SQ; Wang JH; Zhang T
J Thorac Dis; 2019 Dec; 11(12):5433-5439. PubMed ID: 32030262
[TBL] [Abstract][Full Text] [Related]
20. NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myeloma.
Varga G; Mikala G; Andrikovics H; Koszarska M; Balassa K; Ádám E; Kozma A; Tordai A; Masszi T
Br J Haematol; 2015 Mar; 168(5):679-88. PubMed ID: 25363231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
